Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial
- 14 July 2017
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 390 (10098), 959-968
- https://doi.org/10.1016/s0140-6736(17)31327-2
Abstract
No abstract availableKeywords
Funding Information
- academic incentive fund of the Maastricht University Medical Centre (31962340B)
This publication has 30 references indexed in Scilit:
- Predictors for hospitalization and outpatient visits in patients with inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology, 2013
- Quality Indicators for Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2013
- eHealth: individualisation of infliximab treatment and disease course via a self‐managed web‐based solution in Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2012
- Randomized, controlled trial of home telemanagement in patients with ulcerative colitis (UC HAT)*Inflammatory Bowel Diseases, 2012
- The role of self-efficacy in inflammatory bowel disease managementInflammatory Bowel Diseases, 2011
- What Is Value in Health Care?New England Journal of Medicine, 2010
- E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘Constant-care’ approachGut, 2010
- The Triple Aim: Care, Health, And CostHealth Affairs, 2008
- Classification of Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 1989
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986